has reported Consolidated financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 8.3627 crores during the period ended March 31, 2023 as compared to Rs. 5.8707 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. -0.1036 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 0.4584 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. -0.26 for the period ended March 31, 2023 as compared to Rs. 1.15 for the period ended December 31, 2022.
Total Income | ₹8.3627 crs | ₹5.8707 crs | 42.45% |
Net Profit | ₹-0.1036 crs | ₹0.4584 crs | -122.60% |
EPS | ₹-0.26 | ₹1.15 | -122.61% |
Financial Results (Q4 FY2023) - YoY Comparison The company has reported total income of Rs.8.3627 crores during the period ended March 31, 2023 as compared to Rs.6.14 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.-0.1036 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.-0.20 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.-0.26 for the period ended March 31, 2023 as compared to Rs.-0.50 for the period ended March 31, 2022.
Total Income | ₹8.3627 crs | ₹6.14 crs | 36.20% |
Net Profit | ₹-0.1036 crs | ₹-0.20 crs | 48.20% |
EPS | ₹-0.26 | ₹-0.50 | 48.00% |
Financial Results (Year Ended FY2023) - YoY Comparison The company has reported total income of Rs.18.2824 crores during the Financial Year ended March 31, 2023 as compared to Rs.11.2290 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.0.5983 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.0.3330 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.1.50 for the Financial Year ended March 31, 2023 as compared to Rs.0.83 for the Financial Year ended March 31, 2022.
Total Income | ₹18.2824 crs | ₹11.2290 crs | 62.81% |
Net Profit | ₹0.5983 crs | ₹0.3330 crs | 79.67% |
EPS | ₹1.50 | ₹0.83 | 80.72% |
Source : Equity Bulls
Keywords
VivanzaBiosciences
Q4FY23
FY2023
ResultUpdate